Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Mechanisms underlying inflammation in neurodegeneration.

Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH.

Cell. 2010 Mar 19;140(6):918-34. doi: 10.1016/j.cell.2010.02.016. Review.

2.

T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.

González H, Pacheco R.

J Neuroinflammation. 2014 Dec 2;11:201. doi: 10.1186/s12974-014-0201-8. Review.

3.

Neuroinflamm-aging and neurodegenerative diseases: an overview.

Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A.

CNS Neurol Disord Drug Targets. 2011 Aug;10(5):621-34. Review.

PMID:
21631404
4.

RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis.

Ray R, Juranek JK, Rai V.

Neurosci Biobehav Rev. 2016 Mar;62:48-55. doi: 10.1016/j.neubiorev.2015.12.006. Epub 2015 Dec 25. Review.

PMID:
26724598
5.

New developments in understanding and treating neuroinflammation.

Infante-Duarte C, Waiczies S, Wuerfel J, Zipp F.

J Mol Med (Berl). 2008 Sep;86(9):975-85. doi: 10.1007/s00109-007-0292-0. Epub 2008 Jan 15. Review.

PMID:
18196212
6.

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.

Dhib-Jalbut S, Arnold DL, Cleveland DW, Fisher M, Friedlander RM, Mouradian MM, Przedborski S, Trapp BD, Wyss-Coray T, Yong VW.

J Neuroimmunol. 2006 Jul;176(1-2):198-215.

PMID:
16983747
7.

Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.

Stolp HB, Dziegielewska KM.

Neuropathol Appl Neurobiol. 2009 Apr;35(2):132-46. doi: 10.1111/j.1365-2990.2008.01005.x. Epub 2008 Dec 11. Review.

PMID:
19077110
8.

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Mosley RL, Gendelman HE.

Exp Neurol. 2010 Mar;222(1):1-5. doi: 10.1016/j.expneurol.2009.12.018. Epub 2010 Jan 4.

9.

Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System.

Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G.

CNS Neurol Disord Drug Targets. 2016;15(3):329-36. Review.

PMID:
26831258
10.

Neurodegeneration and inflammation.

DeLegge MH, Smoke A.

Nutr Clin Pract. 2008 Feb;23(1):35-41. Review.

PMID:
18203962
11.

Role of neuroinflammation in neurodegenerative diseases (Review).

Chen WW, Zhang X, Huang WJ.

Mol Med Rep. 2016 Apr;13(4):3391-6. doi: 10.3892/mmr.2016.4948. Epub 2016 Feb 29. Review.

12.

Inflammation in neurodegenerative diseases--an update.

Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM.

Immunology. 2014 Jun;142(2):151-66. doi: 10.1111/imm.12233. Review.

13.

Melanocortins as innovative drugs for ischemic diseases and neurodegenerative disorders: established data and perspectives.

Leone S, Noera G, Bertolini A.

Curr Med Chem. 2013 Feb 1;20(6):735-50. Review.

PMID:
23276136
14.

Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.

Fakhoury M.

Neurodegener Dis. 2015;15(2):63-9. doi: 10.1159/000369933. Epub 2015 Jan 15. Review.

PMID:
25591815
15.

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.

Zipp F, Aktas O.

Trends Neurosci. 2006 Sep;29(9):518-27. Epub 2006 Aug 1. Review.

PMID:
16879881
16.

Myeloperoxidase: Bridging the gap in neurodegeneration.

Ray RS, Katyal A.

Neurosci Biobehav Rev. 2016 Sep;68:611-620. doi: 10.1016/j.neubiorev.2016.06.031. Epub 2016 Jun 22. Review.

PMID:
27343997
17.

Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?

Baune BT.

Curr Opin Psychiatry. 2015 Mar;28(2):148-54. doi: 10.1097/YCO.0000000000000140. Review.

PMID:
25602246
18.

Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Vegeto E, Benedusi V, Maggi A.

Front Neuroendocrinol. 2008 Oct;29(4):507-19. doi: 10.1016/j.yfrne.2008.04.001. Epub 2008 Apr 29. Review.

19.

Inflammation and Parkinson's disease.

Wersinger C, Sidhu A.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):221-42. Review.

PMID:
14561187
20.

Nuclear receptors, inflammation, and neurodegenerative diseases.

Saijo K, Crotti A, Glass CK.

Adv Immunol. 2010;106:21-59. doi: 10.1016/S0065-2776(10)06002-5.

PMID:
20728023

Supplemental Content

Support Center